Evidence map›Paper›PMID 39441912›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2024

Decoding Macrophage Heterogeneity to Unravel Vascular Inflammation as a Path to Precision Medicine.

Sarvesh Chelvanambi, Julius L Decano, Holger Winkels, Chiara Giannarelli, Masanori Aikawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. The long noncoding RNAFrontiers in immunology · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Editorial: New trends in vascular biology 2024.Frontiers in cardiovascular medicine · 2025
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarvesh ChelvanambiCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine (S.C., J.L.D., M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0001-9621-0704
Julius L DecanoCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine (S.C., J.L.D., M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0003-0388-3585
Holger WinkelsFaculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine (H.W.), University of Cologne, Germany.ORCID 0000-0003-1333-2031
Chiara GiannarelliCardiovascular Research Center, Division of Cardiology, Departments of Medicine and Pathology, New York University Grossman School of Medicine (C.G.).ORCID 0000-0003-2473-6058
Masanori AikawaCenter for Interdisciplinary Cardiovascular Sciences, Cardiovascular Division, Department of Medicine (S.C., J.L.D., M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA.ORCID 0000-0002-9275-2079

Funding

OTA-21-015A Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: NYU Langone Health Clinical Science Core, Data Resource Core, and PASC Biorepository CoreOT2HL161847 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GROSS, RACHEL SHARON, HORWITZ, LEORA · 2021 to 2025
$651.0M
Dissecting the role of CD8+ T cells in atherosclerosisR01HL153712 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GIANNARELLI, CHIARA · 2020 to 2024
$3.3M
Mechanisms of atherosclerotic cardiovascular complications in COVID19R01HL165258 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GIANNARELLI, CHIARA · 2022 to 2025
$3.1M
Pro-inflammatory activation of human macrophages regulated by lncRNAsR01HL149302 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, MASANORI · 2019 to 2022
$2.9M
PARP9 and PARP14 in atherosclerosisR01HL126901 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI AIKAWA, MASANORI · 2016 to 2019
$2.4M
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIVR01HL174066 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI Elena Aikawa, Masanori Aikawa · 2024 to 2026
$2.2M
Network-driven drug repurposing approaches to treat coronary artery diseaseR21TR001739 · NCATS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BJORKEGREN, JOHAN M, GIANNARELLI, CHIARA · 2016 to 2017
$678k
NCATS NIH HHS R21 TR001739NHLBI NIH HHS OT2 HL161847NHLBI NIH HHS R01 HL126901NHLBI NIH HHS R01 HL149302NHLBI NIH HHS R01 HL153712NHLBI NIH HHS R01 HL165258NHLBI NIH HHS R01 HL174066
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

atherosclerosisinflammationmacrophagesprecision medicinesingle-cell analysistechnologyvascular diseases

Identifiers

PMID39441912
PMCPMC11715277

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.